As of May 27
| +2.75 / +3.36%|
The 15 analysts offering 12-month price forecasts for Incyte Corp have a median target of 90.00, with a high estimate of 115.00 and a low estimate of 65.00. The median estimate represents a +6.47% increase from the last price of 84.53.
The current consensus among 18 polled investment analysts is to Buy stock in Incyte Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.